Naftifine Hydrochloride Cream
Product Images NDC 51672-1368

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naftifine Hydrochloride (NDC 51672-1368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Naftifine 01)

HCI stands for Human-Computer Interaction, which is a field of study focused on the design, development, and evaluation of interactive computer systems. This involves understanding the relationship between humans and computers and creating systems that are intuitive, efficient, and enjoyable to use. HCI draws from a variety of disciplines, including psychology, computer science, design, and engineering, to address the complex issues involved in designing effective human-computer interfaces.*

FDA Label Image

Principal Display Panel (30 g Tube Carton)

This is the description of a cream with the active ingredient Naftifine Hydrochloride (2%). The cream contains several ingredients including benzyl alcohol, cetyl alcohol, and hydrochloric acid. It is for topical use only and should not be used orally, intravaginally, or in the eyes. The usual dosage is not available, but it comes in a pack set with full prescribing information. The tube has a number and expiry date on it. The cream is distributed by Taro Pharmaceuticals and should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.